China STEMI-PCI Program

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01716884

Enrollment

4000

Registered

2012-10-30

Start date

2011-12-31

Completion date

2016-06-30

Last updated

2012-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST Segment Elevation Myocardial Infarction

Keywords

STEMI, reperfution, primary PCI

Brief summary

1. Registration 2. Performing in three stages 3. Major aim: Much more and standard reperfusion therapy in STEMI patients

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Onset of STEMI within 12h * Onset of STEMI within 12-36h needing primary PCI

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
The reperfusion ratio	up to 1 day

Secondary

Measure	Time frame
Door to Balloon time	up to 1 day
BMS ratio	up to 1 day
health economic evaluation	up to 1 year

Countries

China

Contacts

Primary ContactYan Zhang, MD

drzhy1108@163.com8610-83575180

Outcome results